<DOC>
	<DOCNO>NCT00002012</DOCNO>
	<brief_summary>To conduct parallel-group , double-blind , randomize , placebo-controlled study evaluate safety efficacy orally administer low dose interferon alfa-n3 immunomodulator treatment mild moderate symptomatic HIV+ , AIDS-related complex ( ARC ) patient .</brief_summary>
	<brief_title>Double-Blind , Randomized , Placebo-Controlled Study Low Dose Oral Interferon Alfa-n3 ( Human Leukocyte Derived ) ARC Patients</brief_title>
	<detailed_description>The study extend offer 52 week maintenance therapy 10 week placebo control period conclude successfully .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine ( AZT ) . Patients must : Diagnosis AIDS relate complex ( ARC ) . Given write informed consent . Been receive dose = &lt; 600 mg/day zidovudine ( AZT ) least 90 day prior study entry IF currently take AZT . Prior Medication : Allowed : Zidovudine ( AZT ) dose = &lt; 600 mg/day least 90 day prior study entry . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : History AIDSdefining condition evidence AIDS dementia . Evidence chronic hepatitis severe liver dysfunction , active gastrointestinal , renal , respiratory , endocrine , hematologic , cardiovascular psychiatric disorder would limit subject 's ability complete 12 week study period . Concurrent Medication : Excluded : Ketoconazole . Trimethoprim / sulfamethoxazole ( TMP/SMX ) . Experimental medication . Patients follow exclude : Absolute CD4 count &lt; 100 &gt; 350 cells/mm3 . Any disease disorder list Patient Exclusion Coexisting Conditions . Unlikely unable comply requirement protocol . Unwilling unable give inform consent . Development antibodies interferon prior interferon therapy occur &gt; 3 month prior study entry . Prior Medication : Excluded within 45 day study entry : Immunomodulators ( e.g. , BCG vaccine , isoprinosine ) . Chemotherapy . Steroids . Excluded within 3 month study entry : Interferon therapy . Active IV drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1993</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Interferon Type I , Recombinant</keyword>
</DOC>